Related Experiment Video
Updated: May 24, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
The pathogenesis of membranous nephropathy: evolution and revolution
1Geffen School of Medicine, University of California, Los Angeles, California, USA. Glassock@cox.net
Purpose Of Review:
The morphological features of membranous nephropathy have been recognized for over five decades, but the pathogenetic mechanisms underlying this lesion in humans have only recently been elucidated. This review analyzes the recent developments in understanding the pathogenesis of the primary and secondary forms of membranous nephropathy.
Recent Findings:
Seminal studies have identified several autologous antigens that are targets of an autoantibody response in primary membranous nephropathy. The leading candidate autoantigen is M-type phospholipase A2 receptor (PLA2R) protein. Autoantibodies to PLA2R, usually of IgG4 subclass, are found in 70-80% of patients with primary membranous nephropathy, bind to conformational epitopes on PLA2R expressed in the glomerular podocyte, form immune complexes in situ and induce proteinuria, mostly likely via local activation of complement. The autoimmune response is governed by genes at the HLA-DQA1 locus. The level of autoantibody to PLA2R correlates with the severity of the clinical disease and predicts recurrences in renal allografts (at least in some patients). Most forms of secondary membranous nephropathy appear to be due to distinctly different pathogenetic mechanisms.
Summary:
The identification of target antigens provides new tools for diagnosis, prognosis and monitoring of therapy in human membranous nephropathy.
Insights
Primary membranous nephropathy is an autoimmune disease targeting the phospholipase A2 receptor (PLA2R). Autoantibodies to PLA2R are key diagnostic and prognostic markers for this kidney disease.
Area of Science:
- Nephrology
- Immunology
- Pathogenesis of Kidney Disease
Background:
- Membranous nephropathy (MN) morphology is well-established, but human pathogenetic mechanisms are recently understood.
- This review focuses on recent advancements in understanding primary and secondary MN pathogenesis.
Purpose of the Study:
- To analyze recent developments in the pathogenesis of primary and secondary membranous nephropathy.
- To highlight the role of autoantigens and autoantibodies in MN.
Main Methods:
- Review of seminal studies and recent research on MN pathogenesis.
- Analysis of identified autoantigens, autoantibodies, and genetic associations.
Main Results:
- Primary MN involves autoantibodies, predominantly IgG4, targeting M-type phospholipase A2 receptor (PLA2R) in 70-80% of cases.
- PLA2R autoantibodies bind to glomerular podocyte epitopes, forming immune complexes and activating complement, leading to proteinuria.
- The autoimmune response is linked to HLA-DQA1 genes, and PLA2R autoantibody levels correlate with disease severity and allograft recurrence.
Conclusions:
- Identification of target antigens like PLA2R offers new diagnostic, prognostic, and therapeutic monitoring tools for MN.
- Distinct pathogenetic mechanisms are proposed for most forms of secondary MN.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Viral Mutations
Diabetic Nephropathy
Acute Kidney Injury II: Pathophysiology
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Bacterial Meningitis II: Pathophysiology

